President of @EIDS_uae. Transplant ID physician. Adj Associate Prof UAEU. @UMass_ID @UT_infectious @bcm_tropmed alum #TxID #OncID #viewsmyown @docalhammadi
UAE
Joined September 2018
- Tweets1.2K
- Following189
- Followers896
- Likes653
Ahmed AlHammadi retweeted
Fosfomycin’s IV formulation is now being used more widely, particularly in critically ill patients with MDR or DTR-GNB infections
🆕⚡⚡🟢Excellent comprehensive review
Fosfomycin Use in Treating Severe Difficult-to-Treat Gram-Negative Infections
🔻Mechanism of action. Fosfomycin
🔻Antimicrobial Spectrum
🔻Resistance
🔻PK/PD Characteristics
🔻Dosing
🔻TDM
🔻Clinical Trials and Real-World Data
🔻Adverse Events
🔻ESCMID guidelines for the treatment of MDR GNB/fosfomycin
🔻Purposing Fosfomycin in the Treatment of DTR Gram-Negative Infections in Critically Ill Patients #IDXposts
mdpi.com/2079-6382/15/3/234
Ahmed AlHammadi retweeted
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures
✅ Just Accepted
✍️ @UCSFDHM
🔗 bit.ly/43K2IQZ
Ahmed AlHammadi retweeted
Effectiveness and safety of antibiotics in kidney transplant recipients with asymptomatic bacteriuria: a systematic review and meta-analysis of randomised controlled trials
✅ Just Accepted
🔗 bit.ly/4lSOvYd
Ahmed AlHammadi retweeted
Infection risk associated with colonization by multidrug-resistant Gram-negative bacteria: An umbrella review and meta-analysis
✅ Just Accepted
🔗 bit.ly/405Hj2Z
Ahmed AlHammadi retweeted
How safe and effective are MMR and VZV 💉after SOT in children? Pretty safe and pretty effective!
Need details? This 🔥table has it all in one place! The authors also propose inactivated vaccines >2 weeks pre-SOT and live vaccines >4 weeks
transplantid.net/5ZACTPRN
Ahmed AlHammadi retweeted
Cytomegalovirus infection: When and why to detect antibodies.
Serological testing in CMV infection.
mlo-online.com/continuing-ed…
Ahmed AlHammadi retweeted
Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial
✅ Just Accepted
🔗 bit.ly/4kNxyPJ
Ahmed AlHammadi retweeted
We’re proud to announce the new EIDS board! With diverse expertise, they’ll lead us into an exciting new chapter ahead.
We also extend heartfelt gratitude to our outgoing members for their invaluable contributions.
Here's to growth and innovation ahead! #EIDS #Leadership
Ahmed AlHammadi retweeted
It is with profound sadness that we announce the passing of the vice president of EIDS— Dr Emmanuel Nsutebu who was a pillar in UAE’s ID community.
He will forever be remembered for his exemplary approach to his patients & colleagues.
The UAE ID community lost a giant today.
Ahmed AlHammadi retweeted
Vaccines saves lives! 💉
Join us for “Immunization awareness day” an EIDS event that tackles the latest updates in all things vaccines!
#vaccineswork
Register in the link below:
form.jotform.com/24287197016…
Ahmed AlHammadi retweeted
@RxMartinidazole Halo! here is your unroll: threadreaderapp.com/thread/1… Share this if you think it's interesting. 🤖
Ahmed AlHammadi retweeted
Maybe it's time to ditch the Gent from this one, too!
🆕️⚡️ @OFIDJournal
Amoxicillin and ceftriaxone: a synergistic association against Listeria monocytogenes #idxposts academic.oup.com/ofid/articl…
Ahmed AlHammadi retweeted
Patients with serious infections who are cared for by an ID physician have better outcomes, shorter hospital stays & lower healthcare costs, shares @RepRaulRuizMD during today's @HouseAppropsGOP and @AppropsDems "Member Day" hearing.
Thank you for your leadership in urging Congress to fund the Bio-Preparedness Workforce Pilot Program, Rep. Ruiz. #ValueofID
Ahmed AlHammadi retweeted
Scedosporium and lomentospora are two of the nastiest, hardest to treat fungi out there.
@FannyLanternier from 🇫🇷 here updating us at
#eccmid2024 #ESCMIDGlobal @ESCMID @efisg_escmid
Ahmed AlHammadi retweeted
Managing ART for critically ill people with HIV in the ICU is complex. This review explores strategies for optimizing care amidst drug interactions and dosing challenges. Check it out for insights on improving outcomes: doi.org/10.1093/ofid/ofae213
Ahmed AlHammadi retweeted
IDSA and @HIVMA mourn the recent loss of IDSA Past President Barbara E. Murray, MD, FIDSA.
A leading authority on the role of enterococci and S. aureus in infectious diseases from the bench to the bedside, Dr. Murray was president of the Society from 2013 to 2014 and served on the IDSA Board of Directors in multiple roles, including as treasurer and as secretary.
We extend our deepest condolences to her family, friends and colleagues. #WeAreID
Ahmed AlHammadi retweeted
Mortality from mucor is too high. Do combo antifungals help? New 📜 in @OFIDJournal
➡️Mostly LAmB vs. LAmB+Azole
➡️6 wk mortality 31%
➡️No difference w/ upfront or salvage combo rx
Likely some confounding but mucor remains a big issue.
Added to Mucor📁
transplantid.net/PY7DSB99
Ahmed AlHammadi retweeted
【Adjunct terbinafine in patients with leukemia and invasive fusariosis with skin lesions】@OFIDJournal Feb 13, 2024
I’m pleased to announce our another fusariosis report has been out!
👉doi.org/10.1093/ofid/ofae068
@MSG_ERC @MDAndersonNews @UT_Infectious
【Invasive fusariosis in leukemia patients in the era of mold-active azoles】
I’m pleased to share our fusariosis project has been published in JAC!
Grateful to my mentor, Dr. Kontoyiannis, and other co-authors!
doi.org/10.1093/jac/dkad377
@MSG_ERC @MDAndersonNews @UT_Infectious
Ahmed AlHammadi retweeted
More about Epetraborole
nitter.gq/TxIDdoc/status/1583071…
Epetraborole:
A Novel, Oral Antibiotic for NTM
Lung Disease
Paul Eckburg, MD
A new exciting PO workhorse?
#idtwitter #idweek2022
